IDBS Acquires InforSense to Provide End-to-End Solutions for R&D Data Management
News Jun 29, 2009
IDBS has announced that it has concluded an unconditional agreement to acquire InforSense Ltd (InforSense), a company providing scientific and business intelligence (BI) technologies, in an all-cash transaction. The acquisition will complete in July.
R&D organizations in the public and private sectors rely upon their ability to capture, integrate and interpret their data. This is hampered by the explosion in volume and diversity of data available to scientists, the global scale of modern R&D activities and the requirement for data to be accessed and searched in context.
InforSense’s data integration technologies and web-based interactive analytics complement IDBS’ suite of secure, context-rich data management solutions. This transaction creates a supplier who can deliver the entire capture, integration and decision-making infrastructure for R&D organizations worldwide.
With the addition of the InforSense product portfolio, IDBS will expand its large scale data integration activities to support international data sharing and broaden its life sciences portfolio into the emerging growth area of biomarker development and personalized medicine.
Researchers Fine-Tune Computer-Assisted Drug Repositioning Process to Treat Rare DiseasesNews
Researchers at the LSU Computational Systems Biology group have developed a sophisticated and systematic way to identify existing drugs that can be repositioned to treat a rare disease or condition.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018